Hashem Alsaab
Hashem Alsaab
Assistant Professor of Pharmaceutics and Pharmaceutical Technology at Taif University
Verified email at wayne.edu - Homepage
Cited by
Cited by
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers in pharmacology 8, 561, 2017
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery
AK Sharma, A Gothwal, P Kesharwani, H Alsaab, AK Iyer, U Gupta
Drug Discovery Today 22 (2), 314-326, 2017
Advances in antibody–drug conjugates: a new era of targeted cancer therapy
S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer
Drug discovery today 22 (10), 1547-1556, 2017
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy
JM Wickens, HO Alsaab, P Kesharwani, K Bhise, MCIM Amin, RK Tekade, ...
Drug discovery today 22 (4), 665-680, 2017
Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
S Sau, HO Alsaab, K Bhise, R Alzhrani, G Nabil, AK Iyer
Journal of Controlled Release 274, 24-34, 2018
Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers
D Luong, P Kesharwani, HO Alsaab, S Sau, S Padhye, FH Sarkar, AK Iyer
Colloids and Surfaces B: Biointerfaces 157, 490-502, 2017
Nanomedicine for cancer diagnosis and therapy: advancement, success and structure–activity relationship
K Bhise, S Sau, H Alsaab, SK Kashaw, RK Tekade, AK Iyer
Therapeutic delivery 8 (11), 1003-1018, 2017
CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer
Z Wang, S Sau, HO Alsaab, AK Iyer
Nanomedicine: nanotechnology, biology and medicine 14 (4), 1441-1454, 2018
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages
HO Alsaab, S Sau, RM Alzhrani, VT Cheriyan, LA Polin, U Vaishampayan, ...
Biomaterials 183, 280-294, 2018
Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma
H Alsaab, RM Alzhrani, P Kesharwani, S Sau, SHS Boddu, AK Iyer
Pharmaceutics 9 (2), 15, 2017
PDL-1 antibody drug conjugate for selective chemo-guided immune modulation of cancer
S Sau, A Petrovici, HO Alsaab, K Bhise, AK Iyer
Cancers 11 (2), 232, 2019
A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma
VT Cheriyan, HO Alsaab, S Sekhar, C Stieber, P Kesharwani, S Sau, ...
Oncotarget 8 (62), 104928, 2017
Organogels in drug delivery: a special emphasis on pluronic lecithin organogels
H Alsaab, SP Bonam, D Bahl, P Chowdhury, K Alexander, SHS Boddu
Journal of Pharmacy & Pharmaceutical Sciences 19 (2), 252-273, 2016
Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
S Yousef, HO Alsaab, S Sau, AK Iyer
Heliyon 4 (12), e01071, 2018
A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy
S Sau, K Tatiparti, HO Alsaab, SK Kashaw, AK Iyer
Drug discovery today 23 (7), 1344, 2018
Anti-inflammatory effects of a novel ricinoleic acid poloxamer gel system for transdermal delivery
SHS Boddu, H Alsaab, S Umar, SP Bonam, H Gupta, S Ahmed
International journal of pharmaceutics 479 (1), 207-211, 2015
Phage display derived monoclonal antibodies: from bench to bedside
MA Alfaleh, HO Alsaab, AB Mahmoud, AA Alkayyal, ML Jones, SM Mahler, ...
Frontiers in Immunology 11, 2020
Combination of vancomycin and cefazolin lipid nanoparticles for overcoming antibiotic resistance of MRSA
K Bhise, S Sau, R Kebriaei, SA Rice, KC Stamper, HO Alsaab, MJ Rybak, ...
Materials 11 (7), 1245, 2018
Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems
R Alzhrani, HO Alsaab, A Petrovici, K Bhise, K Vanamala, S Sau, ...
Drug discovery today 25 (4), 718-730, 2020
Pregabalin: potential for addiction and a possible glutamatergic mechanism
YS Althobaiti, A Almalki, H Alsaab, W Alsanie, A Gaber, Q Alhadidi, ...
Scientific reports 9 (1), 1-8, 2019
The system can't perform the operation now. Try again later.
Articles 1–20